A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine

A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine

This phase Ⅱ, randomized, controlled trial aimed to evaluate the safety and immunogenicity of a various Sabin IPV preparations. Six hundred infants aged 60 ~ 90 days received one of five different vaccines: low- (group A), medium- (group B) or high-D antigen content (group C) of an experimental Sabi...

Full description

Bibliographic Details
Main Authors: Rong Tang, Guifan Li, Chengfu Zhang, Hengkui Zhi, Jiahong Zhu, Jianjun Wang, Qi Liang, Yuemei Hu, Changgui Li
Format: Article
Language:English
Published: Taylor & Francis Group 2020-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
inactivated poliovirus vaccine
sabin strain
phase ⅱ trial
safety
immunogenicity
Online Access:http://dx.doi.org/10.1080/21645515.2020.1745593

Internet

http://dx.doi.org/10.1080/21645515.2020.1745593

Similar Items